Regeneron Pharmaceuticals
REGN
#250
Rank
HK$746.24 B
Marketcap
HK$7,214
Share price
1.73%
Change (1 day)
41.68%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): HK$292.56

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$328.63. In 2022 the company made an earnings per share (EPS) of HK$317.73 a decrease over its 2021 EPS that were of HK$599.48.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$292.56-7.92%
2022HK$317.73-47%
2021HK$599.48133.36%
2020HK$256.8869.13%
2019HK$151.89-14.44%
2018HK$177.53100.71%
2017HK$88.4531.78%
2016HK$67.1238.96%
2015HK$48.3072.55%
2014HK$27.99-17.55%
2013HK$33.95-44.98%
2012HK$61.71-422.54%
2011-HK$19.1392.13%
2010-HK$9.9649.41%
2009-HK$6.67-15.84%
2008-HK$7.92-36.88%
2007-HK$12.55-9.6%
2006-HK$13.884.12%
2005-HK$13.33-323.68%
2004HK$5.96-135.51%
2003-HK$16.78-24.38%
2002-HK$22.1956.35%
2001-HK$14.19187.3%
2000-HK$4.94-16%
1999-HK$5.88177.78%
1998-HK$2.12-35.71%
1997-HK$3.29-68.42%
1996-HK$10.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.42-84.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.17-87.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
HK$127.19-61.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$14.92-95.46%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$18.51-94.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$155.34-52.73%๐Ÿ‡บ๐Ÿ‡ธ USA